Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17327993 | 1.00 | THRB (0.50) | THRBTSHRPOLBAPEX1HTT | |
| SCHEMBL17327995 | 0.92 | TSHR (0.47) | THRBTSHRPOLBAPEX1HTT | |
| SCHEMBL17327994 | 0.92 | TSHR (0.47) | THRBTSHRPOLBAPEX1HTT | |
| SCHEMBL12539701 | 0.90 | TSHR (0.51) | THRBTSHRPOLBAPEX1HTT | |
| SCHEMBL18962163 | 0.90 | TSHR (0.51) | THRBTSHRPOLBAPEX1HTT | |
| SCHEMBL11802098 | 0.89 | THRB (0.54) | THRBTSHRPOLBAPEX1HTT | |
| SCHEMBL227560 | 0.89 | TSHR (0.47) | THRBTSHRPOLBAPEX1HTT | |
| SCHEMBL3120535 | 0.87 | TSHR (0.57) | THRBTSHRPOLBAPEX1HTT | |
| SCHEMBL28778984 | 0.87 | TSHR (0.49) | THRBTSHRPOLBAPEX1HTT | |
| SCHEMBL10657395 | 0.86 | THRB (0.58) | THRBTSHRPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9534069-B2 | Photocurable composition, barrier layer comprising same, and encapsulated device comprising same | CHEIL INDUSTRIES, INC. (KR) | 2017-01-03 | — | — | US | disclosed |
| US-20150353668-A1 | PHOTOCURABLE COMPOSITION, BARRIER LAYER COMPRISING SAME, AND ENCAPSULATED DEVICE COMPRISING SAME | CHEIL INDUSTRIES INC. (KR) | 2015-12-10 | — | — | US | disclosed |
| US-20150353668-A1 | PHOTOCURABLE COMPOSITION, BARRIER LAYER COMPRISING SAME, AND ENCAPSULATED DEVICE COMPRISING SAME | CHEIL INDUSTRIES INC. (KR) | 2015-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353668-A1 | PHOTOCURABLE COMPOSITION, BARRIER LAYER COMPRISING SAME, AND ENCAPSULATED DEVICE COMPRISING SAME | MCM5, MCM2, MCM7 | THRB 4823/4885TSHR 4831/4885POLB 1249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.